key: cord-0783014-hohybbg3
authors: Kale, Dimitra; Herbec, Aleksandra; Perski, Olga; Jackson, Sarah E.; Brown, Jamie; Shahab, Lion
title: Associations between vaping and Covid-19: cross-sectional findings from the HEBECO study
date: 2021-02-13
journal: Drug Alcohol Depend
DOI: 10.1016/j.drugalcdep.2021.108590
sha: 230f145c9554c2980d0cffc332c2739ca0af22ef
doc_id: 783014
cord_uid: hohybbg3

AIMS: To explore i) associations between vaping and self-reported diagnosed/suspected Covid-19; ii) changes in vaping since Covid-19 and factors associated with these changes; iii) whether Covid-19 motivated current or recent ex-vapers to quit. METHODS: Cross-sectional online survey of 2791 UK adults recruited 30/04/2020–14/06/2020. Participants self-reported data on sociodemographic characteristics, diagnosed/suspected Covid-19, vaping status, changes in vaping and motivation to quit vaping since Covid-19. RESULTS: There were no differences in diagnosed/suspected Covid-19 between never, current and ex-vapers. Bayes factors indicated there was sufficient evidence to rule out small negative (protective) associations between vaping status and diagnosed/suspected Covid-19. Among current vapers (n = 397), 9.7% (95% CI 6.8-12.6%) self-reported vaping less than usual since Covid-19, 42.0% (37.2-46.9%) self-reported vaping more, and 48.3% (43.4-53.2%) self-reported no change. In adjusted analyses, vaping less was associated with being female (aOR = 3.40, 95% CI 1.73-6.71), not living with children (aOR = 4.93, 1.15-21.08) and concurrent smoking (aOR = 8.77, 3.04-25.64), while vaping more was associated with being younger (aOR = 5.26, 1.37-20.0), living alone (aOR = 2.08, 1.14-3.85), and diagnosed/suspected Covid-19 (aOR = 4.72, 2.60-8.62). Of current vapers, 32.2% (95% CI 27.5-36.8%) were motivated to quit vaping since Covid-19, partly motivated by Covid-19, and 21.0%, (10.5-31.4%) of recent ex-vapers quit vaping due to Covid-19. CONCLUSIONS: Among UK adults, self-reported diagnosed/suspected Covid-19 was not associated with vaping status. Half of current vapers changed their vaping consumption since Covid-19, with the majority reporting an increase, and a minority was motivated to quit due to Covid-19. REGISTRATION: The analysis plan was pre-registered, and it is available at https://osf.io/6j8z3/

The World Health Organization (WHO) declared the Covid-19 outbreak a global pandemic in March 2020. Covid-19 is an infectious disease that attacks the human respiratory system and can cause mild to severe illness and death (WHO, 2020) . Using e-cigarettes, or vaping, is not harmless to lung function, but there has been little research on its impact on Covid-19.

Tobacco smoking is more harmful to lungs than vaping (Denholm et organisations have also urged people to stop vaping, claiming that vaping may increase susceptibility to Covid-19, despite little evidence to support this (Rizzo, 2020) .

Irrespective of discussions surrounding potential protective effects of nicotine and whether there are substantial concerns about inhaling and exhaling vapour during a respiratory virus pandemic, it seems likely that the Covid-19 pandemic will have affected rates of vaping. On the one hand, an increase in attempts to stop smoking during the Covid-19 pandemic has been documented Niedzwiedz et al., 2020) , which could have increased uptake of vaping as a cessation aid. On the other hand, vape shops were shut during the UK lockdown, which might have reduced vaping. Data thus far are contradictory: some UK studies have reported reductions in vaping (Niedzwiedz et al., 2020) , and increasing attempts to quit vaping due to concerns about Covid-19 (Tattan-Birch et al., 2020 ). Yet, another study in Italy, where vape shops were open during the lockdown, reported no change in vaping (Caponnetto et. al, 2020) .

Given that e-cigarettes deliver nicotine without many of the harmful toxicants and carcinogens found in cigarette smoke (Shahab et al., 2017) , investigating the association between vaping and Covid-19 infection may help delineate some of the proposed mechanisms for any potential protective or harmful effects of nicotine on Covid-19 outcomes. Further, understanding the impact of Covid-19 on vaping rates can help identify targets for intervention during future periods of social distancing and lockdown measures.

To the best of our knowledge, most of the available research focuses on the relationship between Covid-19 and cigarette smoking, while a limited number of existing studies examine the relationship between vaping and Covid-19 outcomes and behaviour change.

Thus, using cross-sectional data from a survey of UK adults, this study aimed to investigate differences in diagnosed/suspected Covid-19 between vapers, ex-vapers and never vapers as well as self-reported changes in vaping during the Covid-19 pandemic and factors associated with these changes.

Specifically, we aimed to address the following research questions (RQs): 

UK-based adults aged 18 and over who completed the baseline survey of the HEBECO study between 30/04/2020 and 14/06/2020 (covering the period of the first national Covid-19related lockdown in the UK). The UK Coronavirus Action Plan was published on 03/03/2020, followed by government advice to practice social distancing on 16/03/2020 and behavioural restrictions enforceable by law ('lockdown') on 23/03/2020 (Gov.uk, 2020) . On 15/06/2020, most behavioural restriction measures were eased until the autumn.

For the full wording of all measures see Supplementary Materials 1.

J o u r n a l P r e -p r o o f stop using e-cigs and intend to in the next 3 months, (iii)I want to stop using e-cigs and hope to soon, (iv)I REALLY want to stop using e-cigs but I don't know when I will, (v)I want to stop using e-cigs but haven't thought about when, (vi)I think I should stop using e-cigs but don't really want to, (vii)I don't want to stop using e-cigs'. Those who selected (i-v) were considered motivated to quit vaping.

Reasons for motivation to quit vaping included: (1)Rules around social distancing/selfisolation due to Covid-19, (2)Children/parents moved back home due to (3) Money is tighter due to Covid-19, (4)Decided it was too expensive, (5)Health problems/concerns related to Covid-19, (6)Health problems/concerns unrelated to Covid-19, (7)Advice from a GP, (8)Government/Tv/radio/press advert, (9)Social campaign, 

Vaping status was assessed with the question 'Which statement about vaping best describes you?' (adapted from Fidler et al., 2011). Participants were classified as current vapers (daily and non-daily), never vapers, ex-vapers (stopped vaping) and recent ex-vapers (stopped vaping ≤1 year). The latter two groups were not mutually exclusive. We also assessed when recent ex-vapers last vaped. smokers (including smoking cigarettes or using any other tobacco product, daily or nondaily) vs not.

Analyses were conducted on complete cases using SPSS v.26. To account for the nonrandom nature of the sample, all data were weighted to the proportions of sex, age, ethnicity, education, household income and country of living obtained from the Office for National Statistics' Annual Population Survey (2018).

Logistic regression was used to examine associations between vaping status (never vapers (referent), ex-vapers and current vapers) and diagnosed/suspected Covid-19. We constructed three models: i)unadjusted; ii)with adjustment for sociodemographic characteristics; and iii)with additional adjustment for smoking status and health conditions.

To assess possible interactions between cigarette smoking and vaping status this was checked before running the first model.

Where there were non-significant associations between vaping status and diagnosed/suspected Covid-19, Bayes factors (BFs) were used to distinguish inconclusive data from evidence for large, medium or small effects. Large effects in either direction were defined as having an odds ratio OR=4 (positive association) or for lower estimates 1/4 (negative association), based on evidence that current smoking rates among patients hospitalised for Covid-19 in China are four times lower than would be expected from the smoking prevalence in the country (Farsalinos, Barbouni & Niaura, 2020). We defined a medium effect size as OR=2 (positive association) or 1/2 (negative association) and a small effect size as OR=1.5 (positive association) or 2/3 (negative association).

Among current vapers, we report self-reported changes in vaping since Covid-19 (i.e. the proportion who report vaping more, less, or about the same). We used multinomial logistic regression to examine associations of vaping characteristics, sociodemographic characteristics, perceived Covid-19 risk, health conditions, smoking status, and diagnosed/suspected Covid-19 with (i) vaping less, and (ii) vaping more, vs no change (referent). We analysed unadjusted associations (bivariate models) and independent J o u r n a l P r e -p r o o f associations (multivariable model) between each variable and outcome. Among current vapers who reported changes in vaping since Covid-19, we also report reasons for changes in vaping and calculated the proportion (and 95% Confidence Interval (CI)) of current vapers who are motivated to quit and describe their reasons (Covid-19-related vs. non-Covid-19related) for considering stopping vaping.

In recent ex-vapers (those who had stopped vaping in the past 6 months), we calculated the proportion (and 95% CI) who reported quitting vaping due to Covid-19related reasons. We also calculated the proportion (and 95% CI) of recent ex-vapers who reported considering taking up vaping again and their reasons for considering taking up vaping.

The pre-registered protocol for the data analysis of RQ2 specified that logistic regressions would be used to examine associations of sociodemographic and vaping characteristics, (Table 4 ). We also amended the age categories to account for the observation that the number of participants in the category ≥70 years was small.

A total of 2994 (weighted 2792) participants met the inclusion criteria for the study (complete cases) and were included in the present analyses. All the results presented below are weighted (for unweighted results see Supplementary Materials 2). Sample characteristics are shown in Table 1 . Of the analytic sample, three quarters were never smokers and the rest were current or ex-vapers. Overall, one third of participants were aged J o u r n a l P r e -p r o o f 55-64 years, half were female, the majority were of White ethnicity, one third had no post-16 educational qualifications and three quarters had an annual income of less than £50,000.

Of the total sample, 1% (95% CI 0.7-1.4%) reported having a diagnosis of Covid-19 and a further 21.5% (95%CI 19.9-23.0%) reported suspected Covid-19. Table 2 Table 2 ).

Among current vapers, 38 (9.7%, 95%CI 6.8-12.6%) self-reported vaping less than usual since Covid-19, 167 (42.0%, 95%CI 37.2-46.9%) self-reported vaping more, and 192 (48.3%, 95%CI 43.4-53.2%) self-reported no change. Vaping less was independently associated with being female, not living with children and being a current tobacco smoker, while vaping more was independently associated with being younger, living alone, and diagnosed/suspected Covid-19 ( Table 3) .

The most common reason for vaping more was 'out of boredom', followed by 'staying mostly at home where there are fewer/no restrictions' (Table 4 ). Among vapers who reported vaping less, the most commonly specified reason was 'staying at home where there are fewer/no restrictions'. In our sample, there were 128 (32.2%, 95% CI 21.7-37.9%) J o u r n a l P r e -p r o o f current vapers who reported being motivated to quit vaping due to Covid-19, 37 (29.8%, 95% CI 20.7-33.4%) of whom were motivated to do so for Covid-19-related reasons.

There were 62 recent ex-vapers who had quit vaping in the last 6 months and reported reasons for quitting vaping. Of these, 13 ( Table 3 ).

In this sample of UK adults, current vaping was not associated with diagnosed/suspected Covid-19. There was sufficient evidence to rule out a negative (i.e. protective) association between vaping status and diagnosed/suspected Covid-19, but the evidence was insufficient infection between never, current and ex-vapers. In contrast, research on young adults (13-24 years old) in the US suggests that vaping is associated with a diagnosis of Covid-19 (Gaiha et al., 2020) . This study has linked ever but not current vaping to Covid-19, and it was conducted among teens who are more prone than adults to take other risks related to Our data also suggest that some people have reduced their vaping because of staying at home where there are fewer restrictions, with more opportunities to smoke cigarettes.

Being female was also associated with reductions in vaping. During the first national UK lockdown, women reported being busier than ever with an increase in home-schooling, childcare, and care for older people (Engender, 2020). As such, women had less leisure time, which may result in vaping reductions. Of current vapers, 42% self-reported an increase in vaping since Covid-19. We found that younger vapers were more likely than older vapers to report vaping more. Similarly, research in other addictive behaviours has found that younger people were more likely to Our analyses also showed that vapers with diagnosed/suspected Covid-19 had higher odds of reporting vaping more than usual since Covid-19, which may suggest a link between vaping consumption and Covid-19 infection. However, it should be highlighted that our data were cross-sectional and we did not prospectively examine this relationship. Thus, our findings may also suggest that vapers who believe they have/had Covid-19 started vaping more because of stress or believing that nicotine is protective against Covid-19. It is also possible, especially given the small number of confirmed cases of Covid-19 in our sample, that participants may have misinterpreted their symptoms as many other respiratory infections share symptoms with Covid-19.

One third of current vapers reported being motivated to quit vaping and were partly motivated to do so because of Covid-19. However, for most of vapers, their main reason for wanting to quit vaping was unrelated to Covid-19. This is in agreement with research conducted in Italy, which suggests that vapers did not consider stopping vaping during the first Italian lockdown (Caponnetto et al., 2020) . It has also been documented that among cigarette smokers, attempts to quit were triggered by non-Covid-19 related reasons (Tattan-Birch et al., 2020). It is possible that contradictory media reports on the possibility of nicotine being protective against Covid-19 have partly discouraged people to quit vaping and smoking, while influencing recent ex-vapers to consider taking up vaping again. In our sample, 40.7% of recent ex-vapers were considering taking up vaping again since Covid-19 and one of the most common self-reported reasons was because of feeling stressed.

This study has a number of strengths. Data were collected in real-time during the first phase of the Covid-19 pandemic, which reduces the risk of recall bias. The variety of measures collected is another advantage, permitting a detailed analysis of a broad range of potential confounders of the relationship between vaping and diagnosed/suspected Covid-19, and correlates of changes in vaping since Covid-19. However, the study also had several limitations. First, diagnosed/suspected Covid-19 was self-reported and not confirmed with a viral or antibody test. As many other respiratory infections share symptoms with Covid-19, J o u r n a l P r e -p r o o f some participants may have misinterpreted their symptoms. In addition, it is likely that many participants experienced asymptomatic infection (Oran & Topol, 2020 ) and therefore did not report being infected. Second, our measure of vaping less likely underestimated the proportion reducing their vaping as those who quit vaping altogether since Covid-19 were not included in the analyses, while we did not measure attempts to change vaping that were not successful. Additionally, some of those who quit vaping in the last 6 months might have done so before Covid-19 was a serious concern in the UK. Third, other factors which may affect Covid-19 risk, such as compliance with lockdown orders, mask wearing, were not assessed. Fourth, for some analyses the sample size was small, resulting in wide confidence intervals meaning that we likely lacked sufficient power to detect differences (confirmed by BFs, indicating data insensitivity). Fifth, while we weighted the sample to be representative of the UK adult population, it was self-selected and not random which affects the generalisability of the results. Sixth, most of the questions used were adapted from previous research and not validated, while changes in vaping were self-reported. Finally, the data were cross-sectional, and we did not measure the prospective relationship between changes in vaping and potential predictor variables. Longitudinal data following changes in vaping over time as the pandemic continues would be useful in evaluating the extent to which any initial changes in vaping behaviour are maintained over time.

When assessed by self-report in a UK population sample, diagnosed/suspected 

The study has been approved by UCL Research Ethics Committee at the UCL Division of Psychology and Language Sciences (PaLS) (CEHP/2020/579) as part of the larger programme 'The optimisation and implementation of interventions to change behaviours related to health and the environment'. All participants provided fully informed consent. The study is GDPR compliant.

Authors disclosure: DK, AH, OP, SJ declare no conflicts of interest. JB has received unrestricted research grants from Pfizer related to smoking cessation.LS has received honoraria for talks, an unrestricted research grant and travel expenses to attend meetings and workshops from Pfizer and has acted as paid reviewer for grant awarding bodies and as a paid consultant for health care companies. 

Smoking behavior and psychological dynamics during COVID-19 social distancing and stay-athome policies: A survey

Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia

Engender 2020. Sex and power in

The Gender Gap in Mental Well-Being During the Covid-19 Outbreak: Evidence from the UK

Stress related to catching COVID-19 is highest among 30-59 year olds

Smoking, vaping and hospitalization for COVID-19. Qeios

Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system

Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems

The smoking toolkit study: a national study of smoking and smoking cessation in England

Association between youth smoking, electronic cigarette use, and Covid-19

Factors associated with drinking behaviour during COVID-19 social distancing and lockdown among adults in the UK

SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice

Public Health

Clinical characteristics of coronavirus disease 2019 in China

REDCap) A metadata-driven methodology and workflow process for providing translational research informatics support

The REDCap consortium: Building an international community of software platform partners

Measuring the Heaviness of Smoking: Using self-reported time to the first cigarette of the day and number of cigarettes smoked per day

COVID-19, smoking and inequalities: a study of 53 002 adults in the UK

Association of the Covid-19 lockdown with smoking, drinking, and attempts to quit in England: an analysis of 2019-2020 data

How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?

Predictive validity of the Motivation To Stop Scale MTSS): a single-item measure of motivation to stop smoking

The COVID-19 pandemic and changes in adult Brazilian lifestyles: a crosssectional study

Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19

Mental health and health behaviours before and during the COVID-19 lockdown: Longitudinal analyses of the UK Household Longitudinal Study

Office for National Statistics (2020) How has lockdown affected people of different ages?

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Prevalence of asymptomatic SARS-CoV-2 Infection

Disparities in the risk and outcomes from COVID-19

Smokers at greater risk of severe respiratory disease from COVID-19

What You Need to Know About Smoking, Vaping and COVID-19

Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study

The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses

COVID-19, smoking, vaping and quitting: A representative population survey in England

Is there a smoker's paradox in COVID-19?

Self-reported alcohol, tobacco and cannabis use during COVID-19 lockdown measures: results from a web-based survey

An ecological study of socioeconomic predictors in detection of COVID-19 cases across neighborhoods in New York City

Factors associated with COVID-19-related death using Open SAFELY

Tobacco and waterpipe use increases the risk of suffering from COVID-19

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

CI, confidence interval. OR, odds ratio. aOR, adjusted odds ratio. Multivariable model: age, sex, ethnicity, post-16 qualifications, living alone, living with children, income, smoking status, health problems, perceived risk of Covid-19 and confirmed/suspected Covid-19